Company intelligence / Profile preview

International Cell

Miami, Florida, United States

Ownership: Private
Development stage: Other

Overview

International Cell is a biotechnology company focused on the development and administration of advanced cell-based therapies, particularly in the field of regenerative medicine. The company specializes in utilizing stem cell technologies to address chronic conditions, promote anti-aging, and enhance overall wellness. Operating primarily through specialized clinics and partnerships, International Cell provides personalized treatment protocols designed to harness the body's natural healing mechanisms. Their services often include the sourcing, processing, and clinical application of various cell types for therapeutic use.

Therapeutic areas: Other
Modalities: Cell therapyStem cell therapy
Industry: Biotech

Beyond the preview

Go deeper on International Cell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on International Cell.

Explore the full profile